Prostate Cancer Market Size 2020| Future Trends, Growth Analysis, Top Manufacturers and Regional Insights, Forecast To 2025
Market
Research Future (MRFR) has launched a new release on the Prostate Cancer Market
Research Report – Global Forecast till 2025. The report delivers a thorough
understanding of the market’s present status and likely future growth
trajectory over the forecast period.
The
global prostate cancer market was valued at USD 10 billion in 2018 and is
expected to exhibit a strong 7.1% CAGR over the forecast period between 2018
and 2025, according to the latest research report from Market Research Future
(MRFR). The global prostate cancer market is expected to be driven mostly by
the growing awareness about prostate cancer and the increasing entry of
effective prostate cancer medication, according to MRFR.
Segmentation:
The
global prostate cancer market is segmented on the basis of treatment, end user,
and region.
By
treatment, the global prostate cancer market is segmented into surgery and
medication. The medication segment is further sub-segmented into chemotherapy,
targeted therapy, immunotherapy, hormone therapy, monoclonal antibodies, and
others.
By
end use, the global prostate cancer market is segmented into hospitals and
specialty centers.
Regional Analysis:
The
Americas is the largest regional market for prostate cancer, followed by
Europe. The widespread awareness about prostate cancer in North America has
been a vital driver for the global prostate cancer market. According to the
American Cancer Society, prostate cancer is the most common type of cancer
among American men, and over 160,000 new cases were registered in 2018. The
high geriatric population in North America and Europe is also a major driver
for the global prostate cancer market.
Prostate Cancer Market – Competitive Landscape
Highly
competitive, the prostate cancer market appears to be fragmented due to the
presence of several notable players. To gain a substantially large competitive
advantage, these players incorporate strategic initiatives such as mergers
& acquisitions, collaboration, expansion, and product launch. Due to the
increasing strategic partnerships, the structure of the market is changing
rapidly. Besides, the growing competition in the market is encouraging
multinational companies to acquire small yet promising companies operating in
the developing markets.
Get Global Prostate Cancer Research Report: Information by
Treatment [Medication (Chemotherapy, Monoclonal Antibodies, Targeted Therapy,
Immunotherapy and Hormone Therapy) and Surgery], End User (Hospitals &
Clinics, Ambulatory Surgical Centres, Specialty Centres, Others) and Region
(the Americas, Europe, Asia-Pacific and the Middle East & Africa) -
Forecast till 2025
Major Players
Players
leading the global prostate cancer market include Bayer Pharma AG (Berlin),
OncoGenex Pharmaceuticals Inc. (US), Progenics Pharmaceuticals, Inc. (US),
OncBioMune Pharmaceuticals Inc. (US), TOLMAR Inc. (US), Endo Pharmaceuticals
Inc., and Tokai Pharmaceuticals, Inc., among others.
Latest Trending Reports
About US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Comments
Post a Comment